Skip to main content

Table 2 Laboratory indicators

From: GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway

  

VTE group

Control group

Leukocyte (109/l)

 

6.7 ± 3.2

6.1 ± 1.1

Neutrophil (%)

 

62.0 ± 16.7

56.7 ± 10.2

Platelet(109/l)

 

200.1 ± 60.2

184.6 ± 46.6

Erythrocyte distribution width (%)

 

13.1 ± 0.9

13.0 ± 0.6

Thrombocytocrit (%)

 

0.20 ± 0.05

0.20 ± 0.03

Homocysteine (μmol/l)

18.1 ± 6.7*

11.6 ± 2.8

hsCRP (mg/l)

 

2.8(1.0,42.7)*

0.6(0.4,0.9)

CEA (ng/ml)

 

2.56(1.51,17.7)

2.12(1.43,3.10)

GDF15 (pg/ml)

 

568.72(412.66,835.69)*

299.30(271.00,440.14)

  1. *p<0.05